Biomerica Stock (NASDAQ: BMRA) stock price, news, charts, stock research, profile.
Open | $0.910 |
Close | $0.832 |
Volume / Avg. | 83.983K / 90.862K |
Day Range | 0.820 - 0.950 |
52 Wk Range | 0.704 - 2.130 |
Market Cap | $14.679M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 34 |
Short Interest | 0.49% |
Days to Cover | 2.69 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Biomerica (NASDAQ: BMRA) through any online brokerage.
Other companies in Biomerica’s space includes: ENDRA Life Sciences (NASDAQ:NDRA), Predictive Oncology (NASDAQ:POAI), Nexalin Technology (NASDAQ:NXL), Talis Biomedical (NASDAQ:TLIS) and QT Imaging Holdings (NASDAQ:QTI).
The latest price target for Biomerica (NASDAQ: BMRA) was reported by Aegis Capital on Monday, October 19, 2020. The analyst firm set a price target for 11.00 expecting BMRA to rise to within 12 months (a possible 1160.60% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Biomerica (NASDAQ: BMRA) is $0.8726 last updated March 28, 2024 at 5:22 PM EDT.
There are no upcoming dividends for Biomerica.
Biomerica’s Q2 earnings are confirmed for Wednesday, January 11, 2023.
There is no upcoming split for Biomerica.
Biomerica is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.